cc.\*:("002B02B09F")
Resultados 1 a 25 de 4018
Selección :
Molecular Docking of Opiates and Opioid Peptides, a Tool for the Design of Selective Agonists and Antagonists, and for the Investigation of Atypical Ligand-Receptor InteractionsGENTILUCCI, L; TOLOMELLI, A; DE MARCO, R et al.Current medicinal chemistry. 2012, Vol 19, Num 11, pp 1587-1601, issn 0929-8673, 15 p.Article
Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selective μ-antagonist activityIYER, Malliga R; YONG SOK LEE; DESCHAMPS, Jeffrey R et al.European journal of medicinal chemistry. 2012, Vol 50, pp 44-54, issn 0223-5234, 11 p.Article
Stereoselective Synthesis and In Vivo Evaluation of the Analgesic Activity of Polysubstituted BispidinesPLAS, Aurélie; MARCHAND, Fabien; ESCHALIER, Alain et al.European journal of organic chemistry (Print). 2012, Num 30, pp 6070-6079, issn 1434-193X, 10 p.Article
A Novel μ-Opioid Receptor Ligand with High In Vitro and In Vivo Agonist EfficacyLACKO, E; VARADI, A; FÜRST, S et al.Current medicinal chemistry. 2012, Vol 19, Num 27, pp 4699-4707, issn 0929-8673, 9 p.Article
Emerging Targets for the Pharmacological Treatment of Depression: Focus on Melatonergic SystemCATENA-DELL'OSSO, Mario; MARAZZITI, Donatella; ROTELLA, Francesco et al.Current medicinal chemistry. 2012, Vol 19, Num 3, pp 428-437, issn 0929-8673, 10 p.Article
Discovery and evaluation of pyrazolo[1,5-a]pyrimidines as neuropeptide Y1 receptor antagonistsGRIFFITH, David A; HARGROVE, Diane M; CARPINO, Philip A et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 9, pp 2641-2645, issn 0960-894X, 5 p.Article
Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo-pyrimidines as potent human A3 adenosine receptor antagonistsSIEW LEE CHEONG; FEDERICO, Stephanie; VENKATESAN, Gopalakrishnan et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 10, pp 2898-2905, issn 0960-894X, 8 p.Article
Synthesis and SAR studies of novel 2-(4-oxo-2-aryl-quinazolin-3(4H)-yl) acetamide vasopressin V1b receptor antagonistsNAPIER, Susan E; LETOURNEAU, Jeffrey J; GOAN, Katharine A et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 6, pp 1871-1875, issn 0960-894X, 5 p.Article
Synthesis of 6,14-epoxymorphinan derivatives and their pharmacologiesNEMOTO, Toru; YAMAMOTO, Naoshi; WATANABE, Akio et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 3, pp 1205-1221, issn 0968-0896, 17 p.Article
3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammationCHEN, Jian Jeffrey; NGUYEN, Thomas; NISHIMURA, Nobuko et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 11, pp 3384-3389, issn 0960-894X, 6 p.Article
A sucrose-derived scaffold for multimerization of bioactive peptidesRAO, Venkataramanarao; ALLETI, Ramesh; LIPING XU et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 21, pp 6474-6482, issn 0968-0896, 9 p.Article
Capturing of the free cysteine residue in the ligand-binding site by affinity labeling of the ORL1 nociceptin receptorMATSUSHIMA, Ayami; NISHIMURA, Hirokazu; INAMINE, Shogo et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 24, pp 7597-7602, issn 0968-0896, 6 p.Article
Does the combination of optimal substitutions at the C2-, N5- and N8-positions of the pyrazolo-triazolo-pyrimidine scaffold guarantee selective modulation of the human A3 adenosine receptors?SIEW LEE CHEONG; DOLZHENKO, Anton V; PASTORIN, Giorgia et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 20, pp 6120-6134, issn 0968-0896, 15 p.Article
Generation of novel radiolabeled opiates through site-selective iodinationMAJUMDAR, Susruta; BURGMAN, Maxim; HASELTON, Nathan et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 13, pp 4001-4004, issn 0960-894X, 4 p.Article
Molecular probes for the A2A adenosine receptor based on a pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine scaffoldSANTHOSH KUMAR, T; MISHRA, Shilpi; JACOBSON, Kenneth A et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 9, pp 2740-2745, issn 0960-894X, 6 p.Article
Probes for narcotic receptor mediated phenomena. Part 42: Synthesis and in vitro pharmacological characterization of the N-methyl and N-phenethyl analogues of the racemic ortho-c and para-c oxide-bridged phenylmorphansKIM, Jin-Hee; DESCHAMPS, Jeffrey R; ROTHMAN, Richard B et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 11, pp 3434-3443, issn 0968-0896, 10 p.Article
Synthesis, structure·affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonistsLENZI, Ombretta; COLOTTA, Vittoria; LAMBERTUCCI, Catia et al.Bioorganic & medicinal chemistry. 2011, Vol 19, Num 12, pp 3757-3768, issn 0968-0896, 12 p.Article
Naltrexone et traitement substitutif aux opiacés = Naltrexone and Opiate Substitutive TreatmentDUPOUY, Julie; POUTRAIN, Jean-Christophe; LAPEYRE-MESTRE, Maryse et al.Thérapie (Paris). 2011, Vol 66, Num 6, pp 549-552, issn 0040-5957, 4 p.Article
Discovery of spiropiperidine-based potent and selective Orexin-2 receptor antagonistsFUJIMOTO, Tatsuhiko; TOMATA, Yoshihide; KUNITOMO, Jun et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 21, pp 6409-6413, issn 0960-894X, 5 p.Article
Characterization of major degradation products of an adenosine A2A receptor antagonist under stressed conditions by LC-MS and FT tandem MS analysisZHANG, Li-Kang; PRAMANIK, Birendra N.Journal of mass spectrometry. 2010, Vol 45, Num 2, pp 146-156, issn 1076-5174, 11 p.Article
Design and synthesis of conformationally constrained N,N-disubstituted 1,4-diazepanes as potent orexin receptor antagonistsCOLEMAN, Paul J; SCHREIER, John D; WINROW, Christopher J et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 7, pp 2311-2315, issn 0960-894X, 5 p.Article
Discovery of 2-chloro-N-((4,4-difluoro-1-hydroxycyclohexyl)methyl)-5-(5-fluoropyrimidin-2-yl)benzamide as a potent and CNS penetrable P2X7 receptor antagonistXIANGYANG CHEN; PIERCE, Betsy; WIN NAING et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 10, pp 3107-3111, issn 0960-894X, 5 p.Article
Evaluation of N-substitution in 6,7-benzomorphan compoundsPASQUINUCCI, Lorella; PREZZAVENTO, Orazio; RONSISVALLE, Giuseppe et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 14, pp 4975-4982, issn 0968-0896, 8 p.Article
Optimization of isochromanone based urotensin II receptor agonistsLEHMANN, Fredrik; CURRIER, Erika A; OLSSON, Roger et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 13, pp 4844-4854, issn 0968-0896, 11 p.Article
Effentora®-fentanyl OraVescent® (sous forme de citrate)CHARBONNIER, N.La Lettre du cancérologue (Boulogne). 2010, Vol 19, Num 5, issn 1165-113X, I-IVArticle